Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 89976

3 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
April 05, 2022
Product types
Drug
Classifications
Class I and Class II
Statuses
Completed
Recalling firm wording
Cardinal Health Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

3 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 3

Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box, Marketed by Lilly USA, LLC, Indianapolis, IN 46285, Box NDC 0002-8799-59, Pen NDC 002-7516-59

D-0882-2022
Recall number
D-0882-2022
Initiated
April 05, 2022
Classification
Class I
Status
Completed
Recalling firm
Cardinal Health Inc.
Quantity
1 box

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.

Code information

Unknown

Distribution pattern

NM only

drug · product 2 of 3

Trulicity (dulaglutide) injection, 1.5 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 00002-1434-80

D-0883-2022
Recall number
D-0883-2022
Initiated
April 05, 2022
Classification
Class II
Status
Completed
Recalling firm
Cardinal Health Inc.
Quantity
1 box

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.

Code information

Lot #: D482749A, Exp: 10/15/2023.

Distribution pattern

NM only

drug · product 3 of 3

Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80

D-0884-2022
Recall number
D-0884-2022
Initiated
April 05, 2022
Classification
Class II
Status
Completed
Recalling firm
Cardinal Health Inc.
Quantity
1 box

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions

Code information

Lot #: D484557A, Exp: 10/25/2023.

Distribution pattern

NM only